Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Sector Analysis

Surgical & Medical Instruments & Apparatus

Standard Industrial Classification: SIC 3841

Industry Insider Sentiment Analysis

The Surgical & Medical Instruments & Apparatus sector (SIC 3841) acts as a critical barometer for broader economic health. Our real-time monitoring reveals total transactions. Monitoring "cluster buying" is one of the most reliable leading indicators for future sector performance. By analyzing aggregate data across this specific Standard Industrial Classification, investors can filter out individual company volatility and identify high-conviction trends. When multiple directors and officers within the same industry move capital simultaneously, it often signals an upcoming sector-wide revaluation or a fundamental shift in supply chain dynamics that has yet to be recognized by the broader public market.

Filing Date Trade Date Ticker Company Reporting Person Relationship Type Price Qty Total, $ Owned After
2008-06-16 17:59 2008-06-13 ATRC AtriCure, Inc. Drachman David J Director, Officer BUY $10.56 3,200 $33,804 8,400
2008-06-16 20:04 2008-06-13 PDEX PRO DEX INC RITCHEY JEFFREY J Officer BUY $1.07 2,000 $2,136 136,000
2008-06-13 19:06 2008-06-05 ATEC Alphatec Holdings, Inc. Kuyper Dirk Director, Officer BUY $4.54 5,000 $22,680 665,260
2008-06-13 19:30 2008-06-13 DYNT DYNATRONICS CORP CARDON ROBERT J Officer BUY $0.68 6,000 $4,080 31,000
2008-06-13 17:10 2008-06-11 PDII INTERPACE BIOSCIENCES, INC. Marquard Michael Officer BUY $7.99 2,500 $19,971 72,347
2008-06-12 23:31 2008-06-11 ATRC AtriCure, Inc. Drachman David J Director, Officer BUY $10.21 1,200 $12,255 5,200
2008-06-13 01:32 2008-06-12 PDEX PRO DEX INC MURPHY MARK PHILLIP Director, Officer BUY $1.08 5,000 $5,399 453,200
2008-06-12 23:20 2008-05-29 NEP NEPHROS INC Stagg Capital Group LLC 10% owner SELL $0.81 230,900 $186,890 4,166,558
2008-06-13 00:41 2008-06-11 CRY Artivion Inc. RONALD C ELKINS Director SELL $10.55 2,000 $21,094 70,500
2008-06-11 18:54 2008-06-10 ATRC AtriCure, Inc. Drachman David J Director, Officer BUY $10.69 4,000 $42,744 4,000
2008-06-10 22:01 2008-06-10 ATRC AtriCure, Inc. Krell Elizabeth D Director BUY $10.70 500 $5,350 500
2008-06-10 15:16 2008-06-09 ATRC AtriCure, Inc. Hooven Michael D Director BUY $10.36 9,600 $99,492 98,607
2008-06-10 23:48 2008-06-09 PDEX PRO DEX INC JOHNSON PATRICK L Officer SELL $1.35 1,000 $1,350 390,514
2008-06-11 02:03 2008-06-10 CYTX PLUS THERAPEUTICS, INC. CALHOUN CHRISTOPHER J Director, Officer OPT+S $8.34 53,190 $443,780 100,000
2008-06-06 23:18 2008-06-05 PDEX PRO DEX INC JOHNSON PATRICK L Officer SELL $1.35 6,470 $8,735 391,514
2008-06-06 00:00 2008-06-03 LMAT LEMAITRE VASCULAR INC Kamke Trent G Officer OPT+S $3.15 2,797 $8,818 28,683
2008-06-05 00:36 2008-06-04 BAX BAXTER INTERNATIONAL INC MARTIN JOSEPH B Director OPT+S $61.32 10,030 $615,067 2,024
2008-06-04 04:58 2008-03-31 ATEC Alphatec Holdings, Inc. Kuyper Dirk Director, Officer SELL $4.98 17,250 $85,977 660,260
2008-06-03 23:26 2008-05-30 LMAT LEMAITRE VASCULAR INC Kamke Trent G Officer OPT+S $3.25 19,159 $62,290 27,794
2008-06-03 22:08 2008-06-02 PODD INSULET CORP Diehl R Anthony Officer OPT+S $16.35 1,500 $24,525 11,821
2008-06-02 20:27 2008-06-02 RMD RESMED INC FARRELL PETER C Director, Officer SELL $38.55 5,000 $192,736 804,062
2008-06-03 00:15 2008-05-30 LMAT LEMAITRE VASCULAR INC Linden Robert V Officer BUY $3.38 650 $2,197 28,055
2008-06-02 23:15 2008-05-29 BDX BECTON DICKINSON & CO LUDWIG EDWARD J Director, Officer OPT+S $85.19 42,308 $3,604,219 160,393
2008-05-30 20:45 2008-05-28 CRY Artivion Inc. ANDERSON STEVEN G Director, Officer OPT+S $11.12 9,496 $105,610 1,085,384
2008-05-31 00:02 2008-05-28 PDEX PRO DEX INC JOHNSON PATRICK L Officer SELL $1.35 14,476 $19,557 397,984
2008-05-31 01:07 2008-02-04 NEP NEPHROS INC Enso Capital Management LLC 10% owner BUY $0.88 481,165 $423,425 3,446,001
2008-05-31 01:07 2008-01-24 NEP NEPHROS INC Enso Capital Management LLC 10% owner SELL $0.72 481,165 $344,033 221,637
2008-05-30 22:47 2008-05-27 NEP NEPHROS INC Enso Capital Management LLC 10% owner BUY $0.70 1,249,904 $874,933 1,249,904
2008-05-30 21:44 2008-05-27 NEP NEPHROS INC Southpaw Asset Management LP 10% owner SELL $0.70 1,888,075 $1,321,653 103,336
2008-05-31 00:10 2008-05-29 LMAT LEMAITRE VASCULAR INC Pellegrino Joseph P JR Officer BUY $3.59 2,000 $7,180 34,231
2008-05-30 00:09 2008-05-27 BAX BAXTER INTERNATIONAL INC GREISCH JOHN J Officer SELL $59.72 5,500 $328,452 74,383
2008-05-30 00:07 2008-05-27 BAX BAXTER INTERNATIONAL INC GREISCH JOHN J Officer SELL $59.92 10,729 $642,931 79,883
2008-05-30 00:06 2008-05-27 BAX BAXTER INTERNATIONAL INC GREISCH JOHN J Officer SELL $60.10 9,761 $586,684 90,612
2008-05-30 00:04 2008-05-27 BAX BAXTER INTERNATIONAL INC GREISCH JOHN J Officer SELL $60.28 9,100 $548,585 100,373
2008-05-30 00:02 2008-05-27 BAX BAXTER INTERNATIONAL INC GREISCH JOHN J Officer OPT+S $60.46 5,860 $354,301 109,473
2008-05-30 00:02 2008-05-27 BAX BAXTER INTERNATIONAL INC GREISCH JOHN J Officer BUY $60.15 5,000 $300,750 74,383
2008-05-30 00:00 2008-05-27 BAX BAXTER INTERNATIONAL INC BOOMER WALTER E Director OPT+S $60.07 60,328 $3,624,012 21,005
2008-05-29 19:35 2008-05-27 CRY Artivion Inc. McCall Ronald D Director SELL $11.00 9,550 $105,050 140,126
2008-05-28 18:06 2008-05-27 SYK STRYKER CORP STRYKER JON L 10% owner SELL $62.34 7,000 $436,365 4,500
2008-05-28 00:43 2008-05-22 CRY Artivion Inc. ANDERSON STEVEN G Director, Officer OPT+S $10.93 35,504 $388,116 1,085,384
2008-05-28 01:32 2008-05-23 DCTH DELCATH SYSTEMS, INC. Philips Laura A Director BUY $1.73 10,000 $17,334 12,000
2008-05-28 01:07 2008-05-22 RMD RESMED INC EISEN PAUL Officer OPT+S $40.24 8,166 $328,561 0
2008-05-23 20:48 2008-05-21 RMD RESMED INC Sandercock Brett Officer OPT+S $41.13 4,000 $164,500 6,435
2008-05-23 20:44 2008-05-21 RMD RESMED INC QUINN MICHAEL A Director SELL $41.21 10,000 $412,112 139,600
2008-05-24 03:36 2008-05-21 RMD RESMED INC ROBERTS CHRISTOPHER G Director SELL $41.26 15,000 $618,944 248,400
2008-05-23 15:55 2008-05-22 WST WEST PHARMACEUTICAL SERVICES INC ELLERS STEVEN A Officer SELL $47.25 10,000 $472,485 122,889
2008-05-22 21:01 2008-05-21 UFPT UFP TECHNOLOGIES INC GESTAL KENNETH L Director SELL $14.21 10,000 $142,050 10,000
2008-05-22 21:09 2008-05-22 WST WEST PHARMACEUTICAL SERVICES INC JOHNSON L ROBERT Director SELL $47.06 2,500 $117,659 19,532
2008-05-22 17:34 2008-05-21 WST WEST PHARMACEUTICAL SERVICES INC MOREL DONALD E JR Officer SELL $46.47 10,000 $464,727 248,054
2008-05-22 21:04 2008-05-21 UFPT UFP TECHNOLOGIES INC BAILLY R JEFFREY Director, Officer, 10% owner SELL $14.42 400 $5,767 546,347
SHOW ENTRIES

Sector-Wide Insider Alpha

Analyzing insider movements across the Surgical & Medical Instruments & Apparatus sector provides a macro-view of executive conviction. When multiple leaders in different companies within the same SIC code (3841) simultaneously buy shares, it often indicates an industry-wide undervaluation or a positive shift in market cycles.

SEC Filings in Surgical & Medical Instruments & Apparatus

Every transaction in the Surgical & Medical Instruments & Apparatus industry is reported via Form 4 disclosures. By filtering these filings by industry, investors can detect institutional-scale sentiment shifts before they are reflected in broader market indices, following the capital flow of those with intimate industry knowledge.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.